Axel Bolte, MBA
Axel Bolte co-founded Inozyme Pharma and serves as the President and Chief Executive Officer. Prior to joining Inozyme Pharma, Mr. Bolte had a successful 16-year career in healthcare venture capital and served as an investment advisor to HBM Partners AG, where he remains a Venture Partner. During his time as a venture capitalist, Mr. Bolte led multiple biopharma investments and has served on many boards of directors of private and public companies. He is currently a Director of Ophthotech, Nabriva Therapeutics, and Allena Pharmaceuticals.
Mr. Bolte completed studies in biochemistry and organic chemistry at the University of Cambridge and the Swiss Federal Institute of Technology in Zurich, Switzerland. He also earned an MBA from the University of St. Gallen, Switzerland.